The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 06, 2019
Filed:
Jul. 28, 2017
Applicants:
Boehringer Ingelheim Vetmedica Gmbh, Ingelheim am Rhein, DE;
Boehringer Ingelheim Vetmedica S.a. DE C.v., Guadalajara, MX;
Inventors:
Mauricio Realpe-Quintero, Jalisco, MX;
Paulino Carlos Gonzalez-Hernandez, Hamburg, DE;
Eric Vaughn, Ames, IA (US);
Assignee:
Other;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/145 (2006.01); A61K 39/17 (2006.01); C07K 14/005 (2006.01); A61K 39/12 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/145 (2013.01); A61K 39/12 (2013.01); A61K 39/17 (2013.01); C07K 14/005 (2013.01); A61K 2039/5256 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/70 (2013.01); C12N 2710/14043 (2013.01); C12N 2760/16134 (2013.01); C12N 2760/18134 (2013.01);
Abstract
The present invention is based on the surprising finding that H5 protein of clade 1 H5N1 induces, in particular by a single-shot vaccination, a cross-clade protective immune response to influenza viruses with H5N1 HA. In one aspect, the invention is thus directed to H5 protein of clade 1 H5N1 virus for use in a method of treating or preventing infections with H5N1 virus of a different clade, namely of a clade different from clade 1 or from any clade with the exception of clade 1, respectively.